News

The U.S. hemp and CBD processing sector is entering a period of industrial transition, with manufacturers under pressure to demonstrate consistent quality, safety and scalable production. Currently, federal policy discussions are unresolved, with proposals advancing along divergent trajectories. One approach, embodied in the Hemp Enforcement, Modernization, and Protection (HEMP) Act, seeks to eliminate the “hemp loophole” by constraining intoxicating cannabinoid derivatives while maintaining commercial pathways for non‑intoxicating CBD products. A contrasting regulatory signal arises from the . . .

Snoop Dogg is bringing Death Row Records’ cannabis genetics to U.S. growers for the first time, via a new collab with Sensi Seeds. Cannabis & Tech Today discussed the launch with Gio Dronkers from Sensi Seeds. C&T Today: Are you seeing an uptick in homegrown? Gio Dronkers: Yes, we are seeing an uptick because retail price stability for premium flower and high state-level taxation are driving consumers toward more cost-efficient, long-term alternatives. Beyond cost and tech, consumers are increasingly demanding full transparency regarding their product’s cultivation history, choosing to bypass . . .

Another Hawaii House committee has approved a Senate-passed bill that would create a psychedelics task force responsible for studying and making policy recommendations on providing access to breakthrough therapies such as psilocybin and MDMA. The House Finance Committee advanced the legislation from Sen. Chris Lee (D) in a 15-0 vote on Tuesday. The measure, which had cleared the Senate in a unanimous vote of 24-0 last month, next heads to the House floor before potentially going back to the Senate for that chamber to consider recent amendments. The bill would create a Mental Health Emerging . . .

“These results have significant policy implications, particularly with respect to the use of traditional workplace drug testing. It is high-time to abandon these discriminatory methods in favor of performance testing and fit-for-duty testing, which employ measures to assess whether someone is currently under the influence, whether it be from marijuana on anything else.” The post Study: No Measurable Next-Day Cognitive Effects Following Cannabis Use appeared first on NORML.

“Any delay in implementation continues to drive consumers to the illicit market, jeopardizes public safety and delays the tools needed by law enforcement and regulators to address these concerns.” By JM Pedini, NORML Virginia lawmakers did their part by passing a bill this session to legalize and regulate adult-use cannabis sales. Now, it is up to Gov. Abigail Spanberger (D) to finish the job by signing it into law without proposing any amendments to delay the launch of the legal market. Virginia made history in 2021 when it became the first state in the South to legalize marijuana for . . .

ASA Launches the Navarro Family Organ Transplant Resource Center and Calls For End of Medical Cannabis Patient Discrimination Washington, D.C. / San Francisco, CA – Americans for Safe Access (ASA) is mourning the passing of Patrick Navarro, a medical cannabis patient whose experience helped expose a devastating reality: stigma and outdated assumptions about medical cannabis still deny patients fair access to organ transplant opportunities.

Someone in the Trump administration is “holding up” the completion of a marijuana rescheduling proposal, according to a longtime advisor to the president. It’s been more than three months since President Donald Trump issued an executive order directing the Department of Justice to finalize a rule to move cannabis from Schedule I of the Controlled Substances Act to Schedule III “in the most expeditious manner”-but that hasn’t happened. Now, GOP operative Roger Stone is calling out the inaction. “Who is holding up President Trump’s order to reschedule marijuana?” he said in a social media post . . .

Massachusetts lawmakers have passed a bill to double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market, sending it to the governor’s desk. The Senate approved the legislation in a voice vote on Thursday, one day after it cleared the House of Representatives by a unanimous tally of 155-0. The proposal now heads to Gov. Maura Healey (D), who can sign or veto it, allow it to become law without her signature or propose amendments for lawmakers to consider. A bicameral conference committee had spent months working out . . .

The Connecticut Senate has passed a bill to expand a pilot program that’s meant to explore the therapeutic potential of psychedelics such as psilocybin and MDMA. The legislation sponsored by the Joint Committee on Public Health cleared the full Senate in a unanimous 35-0 vote on Wednesday. It now heads to the House of Representatives. If enacted into law, the proposal would build upon an existing psychedelic-assisted therapy program involving military veterans and first responders who elect to participate in clinical trials. The new legislation would repeal and replace the current statute to . . .

Harris Sliwoski is pleased to announce that Christian Sederberg has joined the firm as Of Counsel. Based in our Denver, Colorado office, Christian brings decades of experience advising businesses, policymakers, and industry leaders across a range of complex regulatory and transactional matters, with a particular focus on the cannabis industry. Christian is widely recognized as a leading voice in cannabis law and policy. He has worked at the forefront of the industry’s development, advising clients on business formation, corporate governance, real estate, financing, and regulatory compliance . . .

The Louisiana Senate has passed a bill to let patients with terminal and irreversible conditions use medical marijuana in hospitals. The body approved the legislation, SB 270 from Sen. Katrina Jackson-Andrews (D), in a vote of 33-2 on Wednesday. It now heads to the House of Representatives for consideration. “This bill does exactly what the title says,” Jackson-Andrews said on the floor ahead of the vote. “When a patient is in pain and they believe that therapeutic marijuana will work and have a prescription for it, it allows them to have that prescription delivered to the hospital and . . .

Maryland lawmakers have passed legislation to provide legal protections for veterinarians who recommend medical marijuana to animals, sending the legislation to the governor’s desk. The House of Delegates approved one version of the measure in a unanimous 137-0 vote on Tuesday, weeks after the Senate cleared it by a tally of 45-0. And on Wednesday, the Senate adopted the companion measure 43-0 after it passed the House 136-0 in February. SB 54 from Sen. Clarence Lam (D) and HB 452 from Del. Michele Guyton (D) will now go before Gov. Wes Moore (D), who can sign or veto the bills or allow them . . .

WM Technology Inc (NASDAQ: MAPS) (FRA: 833) has decided to voluntarily delist its Class A common stock and associated warrants from the Nasdaq Global Select Market. The company plans to file the necessary form to do so with the SEC around Apr. 17, setting the final trading day on the exchange on or about Apr. 24. After that date, the shares will move to trading on the OTC Markets. Tuesday’s announcement about the decision triggered an immediate negative reaction in the stock price. Shares closed the regular session on Apr. 7 at 71 cents, down slightly for the day, but the stock dropped by . . .

Medicare’s pilot program covering hemp-derived products has officially launched. Under the plan, Medicare providers can get reimbursed up to $500 per patient annually to discuss and provide certain CBD products. CBD products covered under the plan can’t exceed concentrations of 0.3% of delta-9 THC, or more than 3 milligrams of THC per serving. The products must also be tested by a third party and meet state and local standards. It excludes patients who have certain medical conditions, including substance use disorder and COPD. In an April 1 statement, Centers for Medicare & Medicaid . . .

West Virginia’s treasurer indicated he will release $38 million in medical cannabis derived funding, Mountain State Spotlight reports. The release of the funds comes after Republican Gov. Patrick Morrisey last week vetoed a bill that would have required their distribution. In the veto letter, Morrisey said the state “must do better to plan for the future, and it can’t totally pre-commit future revenue streams like this if it’s going to have reserves to invest more in roads, water, sewer, site selection, rail, and future tax cuts.” Treasurer Larry Pack said the funds will be disbursed . . .

Idaho lawmakers last week passed a resolution that urges voters to reject efforts to place a medical cannabis legalization bill on November ballots, CBS2 reports. The resolution lays out alleged harms caused by cannabis and claims that medical cannabis legalization increases “cartel activity, development of black market marijuana production, human trafficking, and increased crime rates, including violent crime and impaired driving.” The resolution contends that were the issue to appear on ballots and approved by voters, it would increase the administrative budget of the Department of Health . . .

Vireo Growth Inc. Announces Acquisition of The Hawthorne Gardening Company from The Scotts Miracle-Gro Company Transaction further strengthens the Company’s balance sheet with approximately US$110 million of combined cash and net working capital Consideration of 213 million shares at a deemed price of US$0.60 and 80 million warrants at US$0.85 strike price Company has nominated [ . . . ]

Cannabis Home Gardening Advocate Compares Scutari to Trump for Blocking Progress Leading cannabis home gardening advocate Jim Miller of Sativa Cross and the Coalition for Medical Marijuana of NJ (CMMNJ) compared NJ Senate President Nick Scutari (D-22-Union) to President Donald Trump (R) for blocking progress. Scutari, Trump, and No Kings “Preventing (home gardening legalization bill) [ . . . ] Source: Cannabis Home Gardening Advocate Compares Scutari to Trump for Acting Like a King from Heady NJ

Weedmaps parent company WM Technology said it would voluntarily delist from the Nasdaq stock exchange later this month. After going public in 2021 and reaching an all time high above $29 per share, the stock has struggled and currently trades for around 40 cents per share. According to a statement, the company’s decision was affected by several factors including constraints on serving cannabis operators while listed on Nasdaq and struggles the company has faced achieving long term value creation. Founded as a Yelp-like dispensary finder, the company Log in or become a WeedWeek Member to read . . .

Meet ALTERD: the new app to help you explore higher states of mind. The post How ALTERD helps you expand your mind through intentional cannabis consumption appeared first on Leafly.

Sponsored Disclosure: Cannabis Tech (cannabistech.com) sometimes publishes sponsored content created in partnership with brands. These articles are clearly labeled as “Sponsored” and may include paid placements or affiliate links. We maintain full editorial independence and our priority is to provide accurate, unbiased information for our readers. Opinions in sponsored content are those of the author or sponsor and do not necessarily reflect the views of Cannabis Tech. Table of Contents The Hash Star Scale: A Functional Classification of Melt and Purity Star Ranges and Functional Use . . .

Massachusetts House lawmakers have unanimously passed a bill to double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. The House of Representatives approved the legislation in a vote of 155-0 on Wednesday. If the Senate follows suit, which is expected this week, the proposal would head to the desk of Gov. Maura Healey (D), who could then sign or veto it, allow it to become law without her signature or propose amendments for lawmakers to consider. A bicameral conference committee had spent months working out . . .

The cannabis market faces a fundamental problem that’s destroying profitability for licensed producers across North America: mediocrity at scale. Walk into any dispensary and the pattern becomes obvious. Shelves overflow with flower competing on price rather than quality. Consumers face endless options yet leave underwhelmed. The issue isn’t scarcity. It’s that mid-grade product dominates retail spaces, creating a race to the bottom that damages everyone in the supply chain. The True Cost of Growing Mid-Grade Cannabis For commercial cultivators, producing average flower creates a vicious . . .

Virginia’s governor has signed a pair of bills that will legalize a form of psilocybin under state law if and when the psychedelic is approved by federal officials. “Upon approval by the U.S. Food and Drug Administration (FDA) of a formulation of psilocybin designed to be administered by a health care professional in a health care setting, the Board of Pharmacy shall reschedule such formulation of psilocybin consistent with federal scheduling changes and procedures” under state law, the legislation signed on Monday by Gov. Abigail Spanberger (D) says. Under HB 1347 from Del. Laura Jane Cohen . . .

Marijuana sales are increasing as purchases of alcohol are declining, according to a new federal report from the Canadian government. Retailers in the country sold C$5.5 billion worth of legal recreational cannabis products in the fiscal year ending March 31, 2025, Statistics Canada reported, representing a 6.1 percent increase from the previous annual period. Meanwhile, alcohol purchases were down 1.6 percent year over year, a dip that occurred despite a 1.6 increase in retail alcohol prices. The resulting decline in government revenue “was the largest annual decrease since Statistics Canada . . .